Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
817.00    -5.00 (-0.61%)
Bid:
812.00
Ask:
819.00
Spread: 7.00 (0.862%)
Market Cap: £1.13b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Director/PDMR Shareholding

10 Jun 2021 16:56

RNS Number : 5509B
Savills PLC
10 June 2021
Β 

SAVILLS PLC (THE "COMPANY")

TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)

Β 

Vesting of Share Awards

Β 

Awards over ordinary shares of the Company under the Company's Deferred Share Plans have become unconditional in all respects following the end of their Deferred Period. In satisfaction of the Awards, the Trustees of the Group's Employee Benefit Trust effected the transfer of shares, following the settlement of associated tax liabilities through the sale of shares, to Directors and PDMRS of the Company as follows:-

Β 

Director/ PDMR

Number of Shares Transferred

Number of Shares Disposed

Shareholding following this notification

Shareholding as a % of issued share capital

Beneficial interest under the Deferred Share Plans following this notification

Mark Ridley (Director)

48,575

48,575

210,321

0.15

125,119

Simon Shaw (Director)

54,888

54,888

182,579

0.13

123,003

Simon Hope (PDMR)

8,024

8,024

190,958

0.13

11,101

Chris Lee (PDMR)

12,411

12,411

112,138

0.08

25,972

Christian Mancini (PDMR)

9,272

0

137,240

0.10

17,914

James Sparrow (PDMR)

4,602

2,168

53,358

0.04

64,835

Β 

The share price on disposal of all shares was Β£12.128875 per share.

Β 

The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.

1.

Details of the Director/ PDMR

Β 

(a)

Name

1. Mark Ridley

2. Simon Shaw

3. Simon Hope

4. Chris Lee

5. Christian Mancini

6. James Sparrow

Β 

2.

Reason for the notification

Β 

(a)

Position/ status

1. Group Chief Executive/ Director

2. Group Chief Financial Officer/ Director

3. Global Head of Capital Markets/ PDMR

4. Group Legal Director and Company Secretary/ PDMR

5. Chief Executive Officer Asia Pacific (ex-Greater China)/ PDMR

6. CEO, Savills UK & EMEA/ PDMR

Β 

(b)

Initial notification/ Amendment

Β 

Initial notification

3.

Details of the issuer

Β 

(a)

Name

Savills plc

Β 

(b)

LEI

213800WXICGMBWHTA933

Β 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

(a)

Description of the Financial Instrument

Β 

Savills plc Ordinary Shares of 2.5p each

(b)

Identification code of the Financial Instrument

Β 

GB00B135BJ46

(c)

Nature of the transaction

Β 

Vesting of awards under the Company's Deferred Share Plans and sale of resultant shares

Β 

(d)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

Β 

Acquisition

Β£nil per share

Β 

1. 48,575

2. 54,888

3. 8,024

4. 12,411

5. 9,272

6. 4,602

Β 

Disposal

Β£12.128875 per share

1. 48,575

2. 54,888

3. 8,024

4. 12,411

5. 0

6. 2,168

Β 

(e)

Aggregated information

Β 

- Aggregated volume

- Price

Β 

N/A

Β 

Β 

(f)

Date of the transaction

Β 

8 June 2021

(g)

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Name of contact and telephone number for queries:

Chris Lee

Group Legal Director & Company Secretary

020 3107 5444

Β 

10 June 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHKZGMVKGKGMZM
Date   Source Headline
16th Nov 20182:44 pmRNSHolding(s) in Company
13th Nov 20182:46 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSTotal Voting Rights
16th Oct 20183:13 pmRNSHolding(s) in Company
11th Oct 20183:26 pmRNSDirector/PDMR Shareholding
2nd Oct 201812:53 pmRNSDirector/PDMR Shareholding
1st Oct 20187:00 amRNSTotal Voting Rights
28th Sep 201812:28 pmRNSAcquisition
19th Sep 20189:34 amRNSDirectorate Change
18th Sep 20189:56 amRNSDirector/PDMR Shareholding
11th Sep 20181:58 pmRNSDirector/PDMR Shareholding
3rd Sep 20183:50 pmRNSTotal Voting Rights
15th Aug 20183:00 pmRNSBlock listing Interim Review
14th Aug 201811:00 amRNSDirector/PDMR Shareholding
13th Aug 201812:41 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSHalf-year Report
1st Aug 20187:00 amRNSTotal Voting Rights
26th Jul 201811:25 amRNSProposed Acquisition of Minority Interest
26th Jul 201811:19 amRNSAcquisition of Minority Interest
23rd Jul 20187:00 amRNSBlock listing Interim Review
16th Jul 201812:23 pmRNSDirector/PDMR Shareholding
15th Jun 20183:35 pmRNSDirector/PDMR Shareholding
14th Jun 201811:53 amRNSDirector/PDMR Shareholding
13th Jun 201812:00 pmRNSIssue of Equity
1st Jun 20187:00 amRNSTotal Voting Rights
14th May 201810:55 amRNSDirector/PDMR Shareholding
8th May 20184:37 pmRNSResult of AGM
8th May 201812:00 pmRNSAGM Statement
1st May 20187:00 amRNSTotal Voting Rights
26th Apr 20182:54 pmRNSDirector/PDMR Shareholding
25th Apr 20181:31 pmRNSDirector/PDMR Shareholding
18th Apr 201812:00 pmRNSIssue of Equity
17th Apr 201810:00 amRNSDirector/PDMR Shareholding
11th Apr 20181:15 pmRNSDirector/PDMR Shareholding
9th Apr 201812:31 pmRNSAnnual Report and AGM Notice
3rd Apr 20187:00 amRNSTotal Voting Rights
22nd Mar 201810:01 amRNSHolding(s) in Company
15th Mar 20187:00 amRNSFinal Results
13th Mar 20185:21 pmRNSDirector/PDMR Shareholding
13th Feb 20183:04 pmRNSDirector/PDMR Shareholding
22nd Jan 201810:00 amRNSBlock listing Interim Review
16th Jan 20187:00 amRNSSavills Announces Succession Plan
16th Jan 20187:00 amRNSPre-close Trading Update
11th Jan 20184:31 pmRNSDirector/PDMR Shareholding
2nd Jan 20187:00 amRNSTotal Voting Rights
29th Dec 201712:17 pmRNSCompletion of Acquisition
14th Dec 201712:44 pmRNSDirector/PDMR Shareholding
13th Nov 20173:16 pmRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSTotal Voting Rights
12th Oct 20179:41 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.